Retraction Notice to: Dysregulation of miR-551b-5p and SETD2 Predicts Poor Prognosis and Promotes Migration and Invasion of Thyroid Cancers

The article entitled “Dysregulation of miR-551b-5p and SETD2 Predicts Poor Prognosis and Promotes Migration and Invasion of Thyroid Cancers” (2023, 23(11), 1400-1409; has been retracted by the Publisher and the Editor-in-Chief of Endocrine, Metabolic & Immune Disorders - Drug Targets following concerns regarding the statistical validity, methodological details, and reproducibility of the published findings. These concerns, as noted in the published literature, relate broadly to statistical inconsistencies, potential analytical bias, insufficient methodological reporting, and inconsistencies in the description of experimental procedures. The authors were contacted multiple times to provide clarification and supporting information but did not respond. The Publisher also contacted the authors’ institution to seek clarification and information regarding an investigation into these concerns; however, no response or investigation outcome was received. In the absence of sufficient clarification and supporting evidence to resolve these concerns and verify the reliability of the reported findings, the Publisher and the Editor-in-Chief are unable to establish the integrity of the article. The article is therefore retracted to maintain the integrity of the published scholarly record. The original article remains available, marked as retracted, and linked to this notice.